High intensity focused ultrasound hyperthermia for enhanced macromolecular delivery

Journal of Controlled Release

Volumn 241, Issue , 2016, Pages 186-193

  Frazier, Nick ^a,b   Payne, Allison ^c   de Bever, Joshua ^c   Dillon, Christopher ^c   Panda, Apoorva ^b   Subrahmanyam, Nithya ^b   Ghandehari, Hamidreza ^a,b  

^a University of Utah   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery; High intensity focused ultrasound; Hyperthermia; Macromolecular delivery; Magnetic resonance imaging

Indexed keywords

CHELATION; DRUG DELIVERY; FUNCTIONAL POLYMERS; GADOLINIUM; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; MAMMALS; ULTRASONICS;

ABLATIVE THERAPY; FEEDBACK SYSTEMS; HIGH INTENSITY FOCUSED ULTRASOUND; HYPERTHERMIA; MACROMOLECULAR DELIVERY; METHACRYLAMIDES; POLYMER THERAPEUTICS; SUBCUTANEOUS TUMOR;

TUMORS;

EVANS BLUE; GADOLINIUM; N (2 HYDROXYPROPYL)METHACRYLAMIDE; ACRYLAMIDE DERIVATIVE; N-(2-HYDROXYPROPYL)METHACRYLAMIDE; ORGANOMETALLIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; DRUG DELIVERY SYSTEM; HIGH INTENSITY FOCUSED ULTRASOUND; HYPERTHERMIA; IMAGE ANALYSIS; MACROMOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR VOLUME; ADMINISTRATION AND DOSAGE; ANIMAL; DIAGNOSTIC IMAGING; DRUG SCREENING; EXPERIMENTAL NEOPLASM; INBRED MOUSE STRAIN; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; THERMOTHERAPY;

ACRYLAMIDES; ANIMALS; DRUG DELIVERY SYSTEMS; EVANS BLUE; GADOLINIUM; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HYPERTHERMIA, INDUCED; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; MICE, INBRED STRAINS; NEOPLASMS, EXPERIMENTAL; ORGANOMETALLIC COMPOUNDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84988928510     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.09.030     Document Type: Article

References (39)

1. [1] Bae, Y.H., Mrsny, R.J., Park, K., Cancer Targeted Drug Delivery: An Elusive Dream. 2013, Springer Science & Business Media.
2. [2] Chauhan, V.P., Stylianopoulos, T., Boucher, Y., Jain, R.K., Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu. Rev. Chem. Biomol. Eng. 2 (2011), 281–298.
3. [3] Song, C.W., Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 44 (1984), 4721s–4730s.
4. [4] Frazier, N., Ghandehari, H., Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors. Biotechnol. Bioeng. 112 (2015), 1967–1983.
5. [5] Gormley, A.J., Greish, K., Ray, A., Robinson, R., Gustafson, J.A., Ghandehari, H., Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery. Int. J. Pharm. 415 (2011), 315–318.
6. [6] Gormley, A.J., Larson, N., Banisadr, A., Robinson, R., Frazier, N., Ray, A., Ghandehari, H., Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. J. Control. Release 166 (2013), 130–138.
7. [7] Larson, N., Gormley, A., Frazier, N., Ghandehari, H., Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer–drug conjugates and gold nanorod induced hyperthermia. J. Control. Release 170 (2013), 41–50.
8. [8] Gormley, A.J., Malugin, A., Ray, A., Robinson, R., Ghandehari, H., Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment. J. Drug Target. 19 (2011), 915–924.
9. [9] Thomas, J.-L., Fink, M.A., Ultrasonic beam focusing through tissue inhomogeneities with a time reversal mirror: application to transskull therapy. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 43 (1996), 1122–1129.
10. [10] Fry, F.J., Precision high intensity focusing ultrasonic machines for surgery. Am. J. Phys. Med. Rehabil., 37, 1958.
11. [11] Hynynen, K., Freund, W.R., Cline, H.E., Chung, A.H., Watkins, R.D., Vetro, J.P., Jolesz, F.A., A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. RadioGraphics 16 (1996), 185–195.
12. [12] Hynynen, K., MRIgHIFU: a tool for image-guided therapeutics. J. Magn. Reson. Imaging 34 (2011), 482–493.
13. [13] Christensen, D.A., Ultrasonic Bioinstrumentation. 1988, Wiley, New York.
14. [14] Pernot, M., Aubry, J.F., Tanter, M., Thomas, J.L., Fink, M., High power transcranial beam steering for ultrasonic brain therapy. Phys. Med. Biol. 48 (2003), 2577–2589.
15. [15] FDA clears focused ultrasound system for prostate cancer treatment. Oncology Times, 37, 2015, 37.
16. [16] de Smet, M., Heijman, E., Langereis, S., Hijnen, N.M., Grüll, H., Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. J. Control. Release 150 (2011), 102–110.
17. [17] Zhou, Y.-F., High intensity focused ultrasound in clinical tumor ablation. World J. Clin. Oncol. 2 (2011), 8–27.
18. [18] Strohalm, J., Kopeček, J., Poly[N-(2-hydroxypropyl)methacrylamide]. IV. Heterogeneous polymerization. Die Angewandte Makromolekulare Chemie 70 (1978), 109–118.
19. [19] Zarabi, B., Borgman, M.P., Zhuo, J., Gullapalli, R., Ghandehari, H., Noninvasive monitoring of HPMA copolymer–RGDfK conjugates by magnetic resonance imaging. Pharm. Res. 26 (2009), 1121–1129.
20. [20] Zarabi, B., Nan, A., Zhuo, J., Gullapalli, R., Ghandehari, H., HPMA copolymer–doxorubicin–gadolinium conjugates: synthesis, characterization, and in vitro evaluation. Macromol. Biosci. 8 (2008), 741–748.
21. [21] Maruvada, S., Harris, G.R., Herman, B.A., King, R.L., Acoustic power calibration of high-intensity focused ultrasound transducers using a radiation force technique. J. Acoust. Soc. Am. 121 (2007), 1434–1439.
22. [22] Poorter, J.D., Wagter, C.D., Deene, Y.D., Thomsen, C., Ståhlberg, F., Achten, E., Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: in vivo results in human muscle. Magn. Reson. Med. 33 (1995), 74–81.
23. [23] R.D.a.L.G.M.a.B.D.d.S.a.G.S.a.M.K.a.F.M.K.a.W.P.T.M.M.a.C.T., W., Performance analysis of a dedicated breast MR-HIFU system for tumor ablation in breast cancer patients. Phys. Med. Biol., 60, 2015, 5527.
24. [24] Messroghli, D.R., Radjenovic, A., Kozerke, S., Higgins, D.M., Sivananthan, M.U., Ridgway, J.P., Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn. Reson. Med. 52 (2004), 141–146.
25. [25] Gormley, A.J., Larson, N., Sadekar, S., Robinson, R., Ray, A., Ghandehari, H., Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today 7 (2012), 158–167.
26. [26] Frazier, N., Robinson, R., Ray, A., Ghandehari, H., Effects of heating temperature and duration by gold nanorod mediated plasmonic photothermal therapy on copolymer accumulation in tumor tissue. Mol. Pharm. 12 (2015), 1605–1614.
27. [27] Bing, C., Staruch, R.M., Tillander, M., Köhler, M.O., Mougenot, C., Ylihautala, M., Laetsch, T.W., Chopra, R., Drift correction for accurate PRF-shift MR thermometry during mild hyperthermia treatments with MR-HIFU. Int. J. Hyperth. 32 (2016), 673–687.
28. [28] Lam, M.K., Oerlemans, C., Froeling, M., Deckers, R., Barten-Van Rijbroek, A.D., Viergever, M.A., Moonen, C.T.W., Bos, C., Bartels, L.W., DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia. J. Ther. Ultrasound, 4, 2016, 9.
29. [29] Partanen, A., Yarmolenko, P.S., Viitala, A., Appanaboyina, S., Haemmerich, D., Ranjan, A., Jacobs, G., Woods, D., Enholm, J., Wood, B.J., Dreher, M.R., Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery. Int. J. Hyperth. 28 (2012), 320–336.
30. [30] Pichardo, S., Köhler, M., Lee, J., Hynnyen, K., In vivo optimisation study for multi-baseline MR-based thermometry in the context of hyperthermia using MR-guided high intensity focused ultrasound for head and neck applications. Int. J. Hyperth. 30 (2014), 579–592.
31. [31] Tillander, M., Hokland, S., Koskela, J., Dam, H., Andersen, N.P., Pedersen, M., Tanderup, K., Ylihautala, M., Köhler, M., High intensity focused ultrasound induced in vivo large volume hyperthermia under 3D MRI temperature control. Med. Phys. 43 (2016), 1539–1549.
32. [32] Bing, C., Nofiele, J., Staruch, R., Ladouceur-Wodzak, M., Chatzinoff, Y., Ranjan, A., Chopra, R., Localised hyperthermia in rodent models using an MRI-compatible high-intensity focused ultrasound system. Int. J. Hyperth. 31 (2015), 813–822.
33. [33] Owen, S.C., Doak, A.K., Wassam, P., Shoichet, M.S., Shoichet, B.K., Colloidal aggregation affects the efficacy of anticancer drugs in cell culture. ACS Chem. Biol. 7 (2012), 1429–1435.
34. [34] Needham, D., Dewhirst, M.W., The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv. Drug Deliv. Rev. 53 (2001), 285–305.
35. [35] Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000), 271–284.
36. [36] Dickson, J.A., Calderwood, S.K., Temperature range and selective Sensitivity of tumors to hyperthermia: a critical review. Ann. N. Y. Acad. Sci. 335 (1980), 180–205.
37. [37] Grile, G., The effects of heat and radiation on cancers implanted on the feet of mice. Cancer Res. 23 (1963), 372–380.
38. [38] Moricca, G., Cavaliere, R., Caputo, A., Bigotti, A., Colistro, F., Hyperthermic treatment of tumours: experimental and clinical applications. Rossi-Fanelli, A., Cavaliere, R., Mondovì, B., Moricca, G., (eds.) Selective Heat Sensitivity of Cancer Cells, 1977, Springer Berlin Heidelberg, Berlin, Heidelberg, 112–152.
39. [39] Lin, P.S., Ho, K.C., Sung, S.J., Gladding, J., Effect of tumour necrosis factor, heat, and radiation on the viability and microfilament organization in cultured endothelial cells. Int. J. Hyperth. 8 (1992), 667–677.